(Reuters) – Moderna Inc said on Thursday its COVID–19 shot was about 93% effective through six months after the second dose, showing hardly any change from the 94% efficacy reported in its original clinical trial. That compares favorably to data from Pfizer Inc and BioNTech SE last…
Read More
The AstraZeneca vaccine will be used as a third, booster dose for medical personnel before the arrival of the Pfizer vaccine, after which both will be used, according to Thailand’s…
Read More
On Monday, Thailand’s National Communicable Disease Committee (NCDC) approved the use of the AstraZeneca vaccine as a second dose for people who have already received just their first dose of…
Read More
Although only about 10 percent of Thailand’s adult population has had a COVID-19 jab so far, moves to find “booster” doses are already underway. Only two brands of vaccine are…
Read MorePage 1 of 1